Project Grant R01NS146834
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $625,859 to the University of California, Los Angeles under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on January 27, 2026. This Project Grant supports research aimed at developing and validating objective, quantitative measures of infant motor function that serve as predictive biomarkers for Autism Spectrum Disorder (ASD)....
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $395,009 to the University of California, Davis on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The two-year project, extending through July 31, 2027, supports foundational research to develop antisense oligonucleotide (ASO) therapy for ADNP syndrome (Helsmoortel-van der Aa syndrome), a severe...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $115,327 to The Regents of the University of California, San Francisco on August 11, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This Project Grant supports research investigating the protracted maturation and regional migration of cortical inhibitory neurons (CINs) during the perinatal period in the human brain....
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $248,266 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2025, with completion targeted for February 14, 2027. This award supports fundamental neuroscience research investigating how mutations in the CACNA1A gene—which encodes the...
- Federal Grant Award Summary Baylor College of Medicine received a $346,214 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 13, 2025, with completion targeted for October 12, 2027. The research conducted at the Houston, Texas facility investigates causal inference in bimanual tactile processing using a novel tactile paradigm to...
- Federal Project Grant Award Summary The University of Texas at San Antonio received a $109,714 Project Grant award dated August 6, 2025, from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds the Integrating Neuroscience with Developmental and Regenerative Biology (INDARB) training program, an advanced-stage T32 institutional training initiative designed to...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded University of California, Los Angeles $407,739 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This two-year project grant, extending through July 31, 2027, supports basic neuroscience research investigating the regulation of axon caliber in sensory neurons, with particular focus on the role of...
- Summary of Federal Project Grant Award The National Institute of Mental Health (NIMH) awarded The University of Texas Southwestern Medical Center a project grant of $609,386 under the Mental Health Research Grants program (CFDA 93.242) to conduct fundamental research on the regulation and function of DNMT3A-mediated methylation in the brain. The award, effective August 26, 2025, through May 31, 2030, will support research investigating how phosphorylation of the DNA methyltransferase DNMT3A...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $656,879 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2030. This award supports research investigating the mechanisms of glioma initiation driven by isocitrate dehydrogenase (IDH) oncogenes. The research...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $249,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective February 15, 2026, through January 31, 2028. This research initiative will develop and evaluate gene replacement therapy utilizing an adeno-associated virus serotype 9 (AAV9) vector to...
The University of Texas at Austin received a $613,161 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded April 7, 2026, with completion scheduled for March 31, 2031. This research project investigates the role of caldendrin, a calcium-sensing protein, in regulating touch sensation and neurodevelopmental processes related to autism spectrum disorder (ASD). The research builds upon preliminary findings demonstrating that mice lacking caldendrin display tactile hypersensitivity and ASD-like behavioral phenotypes, including anxiety and antisocial behavior with sex-specific differences between males and females. The project will deliver scientific research outputs utilizing advanced biochemistry, electrophysiology, and optical imaging methodologies to elucidate how caldendrin modulates mechanically activated PIEZO2 channels and calcium signaling in dorsal root ganglion neurons during early development. The research aims to identify the mechanistic connections between peripheral sensory neuron dysfunction and central nervous system processes governing cognitive, affective, and social behaviors in adulthood, with implications for understanding the neurobiological basis of touch hypersensitivity in neurodevelopmental disorders. Research outputs will include peer-reviewed publications, experimental data, and potentially translational findings relevant to therapeutic interventions for ASD-related sensory processing abnormalities.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $613.2k | 4/6/26 |